Source: Contract Pharma

CaroGen: CaroGen, BioCentriq Enter Clinical Manufacturing Pact

BioCentriq to provide clinical manufacturing to support Phase 1 clinical trials of CaroGen's lead immunotherapy candidate, CARG-201.

Read full article »
CaroGen's Competitors | CaroGen's News | CaroGen's Financials
Stay up-to-date with the latest news on CaroGen
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Bijan Almassian's photo - President & CEO of CaroGen

President & CEO

Bijan Almassian

CEO Approval Rating

83/100

Read more
Stay up-to-date with the latest news on CaroGen